These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 9027364)

  • 41. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
    Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
    Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sensitive in vitro test systems to determine androgenic/antiandrogenic activity.
    Guth SE; Böhm S; Mussler BH; Eisenbrand G
    Mol Nutr Food Res; 2004 Sep; 48(4):282-91. PubMed ID: 15497179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
    Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
    Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway.
    Jang YG; Go RE; Hwang KA; Choi KC
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells.
    Kollara A; Diamandis EP; Brown TJ
    J Steroid Biochem Mol Biol; 2003 Apr; 84(5):493-502. PubMed ID: 12767274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway.
    Death AK; McGrath KC; Sader MA; Nakhla S; Jessup W; Handelsman DJ; Celermajer DS
    Endocrinology; 2004 Apr; 145(4):1889-97. PubMed ID: 14684616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
    Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Examination of selected food additives and organochlorine food contaminants for androgenic activity in vitro.
    Schrader TJ; Cooke GM
    Toxicol Sci; 2000 Feb; 53(2):278-88. PubMed ID: 10696776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens.
    Avancès C; Georget V; Térouanne B; Orio F; Cussenot O; Mottet N; Costa P; Sultan C
    Mol Cell Endocrinol; 2001 Nov; 184(1-2):13-24. PubMed ID: 11694337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth.
    Minamiguchi K; Kawada M; Ohba S; Takamoto K; Ishizuka M
    Mol Cell Endocrinol; 2004 Feb; 214(1-2):175-87. PubMed ID: 15062556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.
    Szelei J; Jimenez J; Soto AM; Luizzi MF; Sonnenschein C
    Endocrinology; 1997 Apr; 138(4):1406-12. PubMed ID: 9075695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
    Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
    J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line.
    Hofbauer LC; Hicok KC; Khosla S
    J Cell Biochem; 1998 Oct; 71(1):96-108. PubMed ID: 9736458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells.
    Gao J; Isaacs JT
    Cancer Res; 1998 Aug; 58(15):3299-306. PubMed ID: 9699659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulated expression of the prostacyclin receptor (IP) gene by androgens within the vasculature: Combined role for androgens and serum cholesterol.
    Eivers SB; Kinsella BT
    Biochim Biophys Acta; 2016 Oct; 1859(10):1333-51. PubMed ID: 27365208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.